Home - Boston Life Sciences Times

Venture Capital

Neurosterix Raises $105 Million in Series B Financing, Names Three Neuropsychiatry Drug Development Leaders

Life Sciences Times - November 12, 2026

Legal

Massachusetts Jury Awards $3.3 Million in Mesothelioma Case Against Johnson & Johnson

Biotech

Viridian Therapeutics Reports Positive Phase 1 Results for VRDN-008, Plans Myasthenia Gravis Trial in 2027

Biotech

Ginkgo Bioworks Narrows Third-Quarter Loss to $41 Million, Secures Autonomous Lab Deal With Novo

LATEST NEWS

Biotech

Kardigan Reports $591.4 Million Cash Position as Cardiovascular Drug Trials Advance

Life Sciences Times - November 12, 2026 0

SOUTH SAN FRANCISCO, Calif.--Kardigan Inc. (Nasdaq: KARD), a precision cardiovascular medicine company with operations in South San Francisco and Princeton, New Jersey, reported a...

KalVista Presents New Research on Hereditary Angioedema Treatment at ACAAI Annual Meeting

November 12, 2026

enGene Reports Improved Bladder Cancer Trial Results, Plans FDA Submission by Year-End

November 12, 2026

a2z Radiology AI Secures EU Certification for AI Software Detecting 182 CT Scan Findings

November 12, 2026

epocrates Partners With Glass Health to Expand AI-Powered Clinical Decision Support

November 12, 2026

PHARMA

Pharma

KalVista Presents New Research on Hereditary Angioedema Treatment at ACAAI Annual Meeting

Life Sciences Times - November 12, 2026 0

FRAMINGHAM, Mass.--KalVista Pharmaceuticals, now part of the Chiesi Group, is presenting new clinical and real-world research on sebetralstat, a treatment for hereditary angioedema (HAE),...

Takeda Launches First-in-Class Narcolepsy Type 1 Treatment in the United States

November 12, 2026

FDA Approves EMD Serono’s PIMJETMI for Adults with Rare Joint Tumor

November 11, 2026

FDA Approves Johnson & Johnson’s RYBREVANT FASPRO for Advanced Head and Neck Cancer Using Halozyme Technology

November 9, 2026

Boston’s Aisa Pharma Reports Positive Phase 2 Results for Experimental Raynaud’s Disease Treatment

November 9, 2026

Medtech

Medtech

a2z Radiology AI Secures EU Certification for AI Software Detecting 182 CT Scan Findings

Medtech

Myomo Reports Record $12.3 Million in Third-Quarter Revenue, Raises Outlook for 2026

Medtech

Insulet Launches Global Campaign Highlighting Mental Health Challenges of Living With Diabetes

Medtech

BayCare Begins Proton Therapy Treatments Using Mevion’s Next-Generation System in Florida

Real Estate

Real Estate

AstraZeneca Opens $1 Billion R&D Center in Cambridge

Life Sciences Times - October 5, 2026 0

Cambridge, Mass. — AstraZeneca has opened a new global strategic research and development center in Kendall Square as part of a more than $1...

Innovative Industrial Properties Commits $245 Million to Cambridge Life Sciences Campus

October 1, 2026

Bristol Myers Squibb Plans $2.3 Billion Manufacturing Campus in Houston

August 10, 2026

Life Sciences

Thermo Fisher Scientific Launches Lower-Cost qPCR Master Mixes for Research Laboratories

Life Sciences Times - November 5, 2026 0

WALTHAM, Mass.--Thermo Fisher Scientific has introduced two new quantitative polymerase chain reaction (qPCR) master mixes designed to help academic institutions, government laboratories and biotechnology...

Massachusetts and Rhode Island Partner to Develop Regional Biobank for Alzheimer’s Research

Life Sciences Times - October 27, 2026 0

WALTHAM, Mass.--The Rhode Island Life Science Hub and the Massachusetts Life Sciences Center have signed a memorandum of understanding to develop a shared regional...

Zef Scientific and Copia Scientific Partner to Expand Laboratory Automation and Testing Capabilities

Life Sciences Times - October 26, 2026 0

TAUNTON, Mass. — Zef Scientific Inc., a provider of laboratory analytical instruments and services, and Massachusetts-based Copia Scientific announced a partnership to deliver integrated...

Thermo Fisher Scientific Reports 9% Revenue Growth to $12.14 Billion in Third Quarter

Life Sciences Times - October 21, 2026 0

WALTHAM, Mass. — Thermo Fisher Scientific Inc. reported a 9% increase in third-quarter revenue to $12.14 billion, supported by strong organic growth, higher earnings...

Connecticut Teen Raji Doshi, 13, Named America’s Top Young Scientist for Ocean Conservation Invention

Life Sciences Times - October 15, 2026 0

ST. PAUL, Minn. — Raji Doshi, a 13-year-old student from Farmington, Connecticut, has been named America's Top Young Scientist after developing an innovative system...

Today's Headlines

Legal

Massachusetts Jury Awards $3.3 Million in Mesothelioma Case Against Johnson & Johnson

Life Sciences Times - November 10, 2026

Biotech

Palleon Pharmaceuticals Reports Promising Phase 2 Results for Experimental Kidney Disease Treatment

Life Sciences Times - November 11, 2026

Venture Capital

Neurosterix Raises $105 Million in Series B Financing, Names Three Neuropsychiatry Drug Development Leaders

Life Sciences Times - November 12, 2026

Advertisment

LATEST ARTICLES

Biotech

Kardigan Reports $591.4 Million Cash Position as Cardiovascular Drug Trials Advance

Life Sciences Times - November 12, 20260

Pharma

KalVista Presents New Research on Hereditary Angioedema Treatment at ACAAI Annual Meeting

Life Sciences Times - November 12, 20260

Biotech

enGene Reports Improved Bladder Cancer Trial Results, Plans FDA Submission by Year-End

Life Sciences Times - November 12, 20260

Medtech

a2z Radiology AI Secures EU Certification for AI Software Detecting 182 CT Scan Findings

Life Sciences Times - November 12, 20260

Technology

epocrates Partners With Glass Health to Expand AI-Powered Clinical Decision Support

Life Sciences Times - November 12, 20260

Pharma

Takeda Launches First-in-Class Narcolepsy Type 1 Treatment in the United States

Life Sciences Times - November 12, 20260

People on the Move

Cognito Appoints Urvashi Tyagi, Joe Perekupka and Dave Watson to Executive Leadership Team

Life Sciences Times - November 12, 20260

Venture Capital

Neurosterix Raises $105 Million in Series B Financing, Names Three Neuropsychiatry Drug Development Leaders

Life Sciences Times - November 12, 20260

Biotech

Palleon Pharmaceuticals Reports Promising Phase 2 Results for Experimental Kidney Disease Treatment

Life Sciences Times - November 11, 20260

People on the Move

Within3 Names Former IQVIA Executive Ira Daly as Chief Operating Officer

Life Sciences Times - November 11, 20260

12 3...938 Page 1 of 938

Most Popular

Kardigan Reports $591.4 Million Cash Position as Cardiovascular Drug Trials Advance

November 12, 2026

KalVista Presents New Research on Hereditary Angioedema Treatment at ACAAI Annual Meeting

November 12, 2026

enGene Reports Improved Bladder Cancer Trial Results, Plans FDA Submission by Year-End

November 12, 2026

a2z Radiology AI Secures EU Certification for AI Software Detecting 182 CT Scan Findings

November 12, 2026

Recent Comments